Navigation Links
Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's
Date:7/17/2008

el of PD-associated gastrointestinal (GI) dysfunction. She will use the model to test drugs that can alleviate this 'non-motor' symptom, which might also allow for better delivery of existing drugs such as levodopa that must pass through the GI tract to enter the bloodstream.

The following is a complete list of researchers who were awarded grants under Target Validation 2007. For grant abstracts and researcher bios, visit www.michaeljfox.org.

  • Roger J. Colbran, PhD, and Ariel Deutch, PhD,Vanderbilt University School of Medicine
    "CaMKII as a Therapeutic Target in Parkinson's Disease"

  • Ann M. Graybiel, PhD, Massachusetts Institute of Technology
    "Evaluation of the Striatum-enriched Genes CalDAG-GEF1 and CalDAG-GEF2 as Targets for the Treatment and Prevention of L-DOPA Induced Dyskinesia"

  • Pamela J. McLean, PhD, Massachusetts General Hospital (Harvard University)
    "Hsp90 as a Target for Neuroprotective Agents in Parkinson's Disease"

  • Kalipada Pahan, PhD, Rush University Medical Center
    "NBD Peptides in a Non-Human Primate Model of Parkinson's Disease"

  • Yvette F. Tache, PhD, University of California, Los Angeles
    "Mu Opioid Receptors as a Drug Target for Treating Motor Fluctuations in PD"

  • Malu G. Tansey, PhD, University of Texas Southwestern Medical Center
    "Dopaminergic Neuroprotection by Regulator of G-protein Signaling 10 (RGS10)"

  • Stephen F. Traynelis, PhD, and Stella Papa, MD, Emory University School of Medicine
    "Validation of the NR2D Subunit of the NMDA Receptor as a Therapeutic Target for Parkinson's Disease"

  • Danny G. Winder, PhD, Roger Colbran, PhD, and Eric Delpire, PhD, Vanderbilt University School of Medicine
    "NR2B as a Therapeutic Target in Parkinson's Disease"

  • Benjamin Wolozin, MD, PhD, Boston University School of Medicine
    "SIRT1 Activators as Therap
    '/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
2. American Society for Microbiology honors Michael Bruce Zwick
3. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
4. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
5. Neuroscientist Michael Gazzaniga awarded Humboldt Prize
6. Balzan Foundation announces 2007 winners
7. Keck Foundation funds study of biological interactions with nanomaterials
8. Yu receives research funding from the Wallace H. Coulter Foundation
9. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
10. Simons Foundation awards Emory scientists $3M for autism gene research
11. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...on a previously unknown relationship between stem ...hondria a cell,s energy makers. Stem cells with mo...y to differentiate and are more likely to form tum...BC, could lead to methods of enriching the best st... may provide some insights into the role of stem c...
(Date:10/10/2008)...nvestigators from the Herman B Wells Center for Pe...of Medicine are focusing on a family of blood prot... toxic effects of chemotherapy in children and adu...evelopment of targeted therapies for leukemia, mul...The researchers, led by Kristin T. Chun, Ph.D., as...
(Date:10/10/2008)...Peninsula Medical School in Plymouth, UK, have car...derate exercise a day recommended to children from...sing problem of childhood obesity. , Their resea... the journal "Archives of Diseases in Childhood." ...ch has followed the development of over 200 childr...
(Date:10/10/2008)...ing the 1950s, Austrian and Swiss scientists condu...pal taking photographs of the glaciers, mountains ...ologist Fritz Mller spent eight months in the regi...otographing the Himalayan glaciers. , Now, fifty...n by these scientists are of immense value in tryi...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2Recommendations for children's exercise lacking say experts 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 1NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 2NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 3NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 4NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 5China Technology Announces Entry to the Solar Energy Sector 431 1China Technology Announces Entry to the Solar Energy Sector 431 2China Technology Announces Entry to the Solar Energy Sector 431 3NuVasive to Host Investor Reception on September 11 2007 429 1NuVasive to Host Investor Reception on September 11 2007 429 2NuVasive to Host Investor Reception on September 11 2007 429 3NuVasive to Host Investor Reception on September 11 2007 429 4Microarray provides 3 genomic guides to breast cancer treatment decisions 750 1Microarray provides 3 genomic guides to breast cancer treatment decisions 750 2Microarray provides 3 genomic guides to breast cancer treatment decisions 750 3Microarray provides 3 genomic guides to breast cancer treatment decisions 750 4
...combination therapy drastically reduces the infect...ransplant patients with compromised immune systems... edition of Nature Medicine, originate from a stud...hodist Hospital, and Texas Children,s Hospital. ,...The phase 1 trial, funded by the National Heart, L...
...paint for a living may be placing their unborn chi...irth weight. , A study of construction workers in...ity of Alberta in Edmonton, Canada, links low birt...xposure to organic solvents such as paints, thinne...ry in its parent-reported assessment of birth outc...
...published study by investigators at the Center for...gno Rodríguez, MD, along with a nationwide team of...l thinking about the role of measurements of the a... predicting a patient,s ability to fight off the d...of JAMA (Journal of the American Medical Associati...
...ons in the receptor for a known inflammatory respo...isease and ulcerative colitis, according to a repo...chers in the October 26 online Science Express. , ...ly called inflammatory bowel disease (IBD), are ch...a and gastrointestinal bleeding and affect over on...
Other Biology News:Three-in-one virus killer prevents common, often fatal infections 2Solvent exposure linked to birth defects in babies of male painters 2AIDS study challenges conventional treatment guidelines for HIV patients 2AIDS study challenges conventional treatment guidelines for HIV patients 3Crohn's disease gene identified 2
(Date:10/10/2008)... /- Takeda Pharmaceutical Company,Lim... Research and,Development Center, Inc., a wholly o...ification that the U.S. Food and Drug Administrati...f the alogliptin New Drug Application,(NDA) by the...tober 27,2008., "In our most recent discussion w...
(Date:10/9/2008)..., 2008 -- New analytical tools coming on line at t...ergy,s state-of-the-art neutron science facility a...ne dedicated to nuclear physics studies. , The F...ened its shutter to receive neutrons for the first...or the new, intense beam line are experiments that...
(Date:10/9/2008)...Operating Income Excluding Non-Cash Charges, SAN ...mics (Nasdaq:,CDIC), the innovator and leader of B...day reported financial results for fiscal third qu...2008 Compared with Third Quarter 2007 -- Net ICG ...illion -- International sales increased 35% to $6...
(Date:10/9/2008)...xt generation of Qoustic Wound Therapy System(R), ...cal, LLC, a leader in,advanced ultrasonic wound ca...resident and CEO Eliaz Babaev, Ph.D., has been iss...in the next generation of the,company,s Qoustic Wo... System, which offers a safe, cost-effective,alter...
Breaking Biology Technology:FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Spallation Neutron Source sends first neutrons to 'Big Bang' beam line 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 3CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 5CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 6Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology 2
...A silencing , products available from... the <A , href="http://www...., href="http://www.ambion.com/catalog/...on Kit . While this kit is very cost effective whe...es need to be made, it can be , advan...
...-PCR on Sympathetic Neuron Lysates , , Sile...lidated siRNAs , , ...Neuron Lysates , Quantitative RT-PCR i... for measuring mRNA levels from small numbers of c...an be difficult when cell samples are , ...
... siRNA , Construction Kit uses ... column purification to prepare transfect...it, multiple siRNAs can be prepared in ~24 hours. ...iRNAs prepared by the , Silenc... in gene silencing studies. , ...
..., Wollheim CB , (2004) Synaptot... Ca 2+ -dependent insulin exocytosis. J Cell ,... In a recently published paper in the ...i and colleagues used Ambions , ...ctor in , an extensive study to...
Other Biology Technology:Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA 2Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA 3YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 2YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 3YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 4YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 5Your Data: Silencing Hepatitis C Virus Replication With In Vitro Transcribed siRNAs 2Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 2Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 3Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 4
...lity ISO 9001:2000 Certified USDA Research Regist... Validated, SOP's Training AALAS Certified Techn...res GLP Documentation Upon Request Focus CRP is ...mmunology service needs. We offer free project co...
Request Info
IC50: 190 pg/ml · Limit of detection: 60 pg/ml
Request Info
Biology Products: